LISATA THERAPEUTICS
Biotechnology company with a recent SEC Form D offering.
Biotechnology company headquartered in BASKING RIDGE, NEW JERSEY. Filed SEC Form D on 20261002 for a $351.9M Regulation D offering.
Biotech
📍 BASKING RIDGE, NEW JERSEY
Current Valuation
Private
PRIVATE
IPO Outlookprivate
Is LISATA THERAPEUTICS going public?
No. LISATA THERAPEUTICS is private and has not filed to go public. There is no S-1 on file.
What is LISATA THERAPEUTICS' valuation in 2026?
No confirmed valuation is on record for LISATA THERAPEUTICS. The roster shows funding and investors where they are public; it does not estimate a mark.
Has LISATA THERAPEUTICS filed an S-1?
No public S-1 is on file for LISATA THERAPEUTICS.
How much has LISATA THERAPEUTICS raised?
LISATA THERAPEUTICS has raised $351.9M in total, most recently a Form D filing of $351.9M in 20261002.
Is LISATA THERAPEUTICS publicly traded — can you buy LISATA THERAPEUTICS stock?
No. LISATA THERAPEUTICS is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for LISATA THERAPEUTICS on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
HQ
BASKING RIDGE, NEW JERSEY
Growth
Filed SEC Form D on 20261002 for $351.9M Regulation D offering
Last Round
Form D filing — $351.9M (20261002)
Fundraising Status
Form D filing · $351.9M
privateTotal raised $351.9M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Form D filing | $351.9M | 20261002 | — | — |
Vertical Intelligence — Biotech / Gene Therapy
Registered trials
17
0 active · 0 recruiting
Lead phase
Phase 3
most advanced registered study
Focus areas
Myocardial Ischemia
Pancreatic Ductal Adenocarcinoma · Coronary Microvascular Dysfunction
Latest trial start
2030-01
Talent Signal
No public careers page or job board could be found for LISATA THERAPEUTICS as of 2026-11-05. That itself is a datapoint: no open external hiring surface.
Checked the company site and major hosted job boards. Re-checked monthly.
BiotechForm DRecently Funded
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.